Diagnosed or prescribed only? A national analysis of initial evaluation and management of insomnia among older adult Medicare beneficiaries.
Medicare
board certification
health services
older adults
sleep
sleep medicine
Journal
Sleep advances : a journal of the Sleep Research Society
ISSN: 2632-5012
Titre abrégé: Sleep Adv
Pays: United States
ID NLM: 101774029
Informations de publication
Date de publication:
2021
2021
Historique:
received:
15
06
2021
revised:
06
10
2021
pubmed:
15
10
2021
medline:
15
10
2021
entrez:
16
5
2023
Statut:
epublish
Résumé
To describe initial insomnia-related encounters among a national sample of Medicare beneficiaries, and to identify older adults at risk for potentially inappropriate prescription insomnia medication usage. Our data source was a random 5% sample of Medicare administrative claims data (2006-2013). Insomnia was operationalized as International Classification of Disease, Ninth Revision, Clinical Modification diagnostic codes. Insomnia medications included FDA-approved insomnia-related medication classes and drugs. Logistic regression was employed to identify predictors of being "prescribed only" (i.e., being prescribed an insomnia medication without a corresponding insomnia diagnosis). A total of Fewer than half of Medicare beneficiaries prescribed insomnia medications ever received a formal sleep-related diagnosis.
Identifiants
pubmed: 37193565
doi: 10.1093/sleepadvances/zpab017
pii: zpab017
pmc: PMC10104397
doi:
Types de publication
Journal Article
Langues
eng
Pagination
zpab017Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of Sleep Research Society.